Tai‐Wei Ye

Zhejiang Provincial People's Hospital

Papers

2

Total Citations

11

H-Index

2

About

Dr. Tai-Wei Ye is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). His major contributions center on comparing the safety and efficacy of laparoscopic versus robotic complex hepatectomy, providing critical evidence to guide surgical decision-making. In his landmark 2024 multicenter propensity score-matched study, Dr. Ye demonstrated that robotic complex hepatectomy offers comparable perioperative morbidity to laparoscopic approaches for solitary HCC, with the potential for enhanced precision in challenging resections. This work, which has already garnered over 11 combined citations, is shaping best practices in high-volume liver surgery centers. By rigorously analyzing real-world outcomes across multiple institutions, Dr. Ye’s research helps surgeons optimize patient selection and operative technique, ultimately improving recovery and reducing complications. His findings are particularly impactful for trainees and specialists seeking to adopt or refine robotic liver surgery, establishing him as a rising authority in the field of minimally invasive hepatobiliary oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
11
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Multicenter propensity score-matched analysis to compare perioperative morbidity after laparoscopic or robotic complex hepatectomy for solitary hepatocellular carcinoma
9 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 29
🏛 Institutions: Zhejiang Provincial People's Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago